Toroso Investments LLC Sells 1,461 Shares of The Allstate Co. (NYSE:ALL)

Toroso Investments LLC trimmed its position in The Allstate Co. (NYSE:ALL) by 12.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,311 shares of the insurance provider’s stock after selling 1,461 shares during the quarter. Toroso Investments LLC’s holdings in Allstate were worth $1,143,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Apollon Wealth Management LLC raised its position in shares of Allstate by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 3,214 shares of the insurance provider’s stock worth $436,000 after purchasing an additional 78 shares during the last quarter. BLB&B Advisors LLC raised its position in shares of Allstate by 2.9% during the 1st quarter. BLB&B Advisors LLC now owns 3,194 shares of the insurance provider’s stock worth $354,000 after purchasing an additional 91 shares during the last quarter. CVA Family Office LLC raised its position in shares of Allstate by 48.4% during the 1st quarter. CVA Family Office LLC now owns 282 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 92 shares during the last quarter. Bison Wealth LLC raised its position in shares of Allstate by 3.2% during the 1st quarter. Bison Wealth LLC now owns 2,943 shares of the insurance provider’s stock worth $348,000 after purchasing an additional 92 shares during the last quarter. Finally, Dakota Wealth Management raised its position in shares of Allstate by 0.7% during the 1st quarter. Dakota Wealth Management now owns 12,938 shares of the insurance provider’s stock worth $1,434,000 after purchasing an additional 94 shares during the last quarter. 77.23% of the stock is owned by institutional investors.

Allstate Stock Performance

NYSE:ALL opened at $108.78 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. The stock has a market capitalization of $28.45 billion, a P/E ratio of -10.51 and a beta of 0.57. The company has a 50 day moving average price of $108.31 and a 200 day moving average price of $111.55. The Allstate Co. has a fifty-two week low of $100.57 and a fifty-two week high of $142.15.

Allstate (NYSE:ALL) last posted its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported ($4.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.83) by ($0.59). The company had revenue of $13.98 billion for the quarter, compared to analysts’ expectations of $12.30 billion. Allstate had a negative return on equity of 14.69% and a negative net margin of 4.80%. The business’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same period in the previous year, the business posted ($0.76) EPS. Equities research analysts forecast that The Allstate Co. will post -1.99 EPS for the current year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 2nd. Investors of record on Thursday, August 31st will be given a dividend of $0.89 per share. The ex-dividend date is Wednesday, August 30th. This represents a $3.56 dividend on an annualized basis and a dividend yield of 3.27%. Allstate’s payout ratio is currently -34.40%.

Insider Buying and Selling

In related news, Director Judith A. Sprieser sold 1,565 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $111.22, for a total transaction of $174,059.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. JPMorgan Chase & Co. cut their price objective on shares of Allstate from $162.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, August 2nd. StockNews.com assumed coverage on shares of Allstate in a report on Thursday, August 17th. They issued a “hold” rating for the company. Bank of America cut their price objective on shares of Allstate from $143.00 to $138.00 in a report on Wednesday, August 2nd. Piper Sandler cut their price objective on shares of Allstate from $137.00 to $124.00 and set an “overweight” rating for the company in a report on Thursday, August 3rd. Finally, Raymond James cut their price objective on shares of Allstate from $155.00 to $145.00 and set a “strong-buy” rating for the company in a report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Allstate currently has a consensus rating of “Moderate Buy” and an average target price of $135.31.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; other personal lines products; and commercial lines products under the Allstate and Encompass brand names.